Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malachi Griffith

Showing results (61-70 of 164) with videos related to

Pageof 17
Sort By:
Nature Genetics|November 7, 2018
A deep learning approach to automate refinement of somatic variant calling from cancer sequencing dataBenjamin J Ainscough, Erica K Barnell, Peter Ronning, et al.
Cell Reports|August 23, 2018
Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular HeterogeneityKatie M Campbell, Tianxiang Lin, Paul Zolkind, et al.
BMC Genomics|October 3, 2006
Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approachMatthew N Bainbridge, René L Warren, Martin Hirst, et al.
Arxiv|July 1, 2024
pVACview: an interactive visualization tool for efficient neoantigen prioritization and selectionHuiming Xia, My Hoang, Evelyn Schmidt, et al.
Genome Research|October 14, 2008
In-depth characterization of the microRNA transcriptome in a leukemia progression modelFlorian Kuchenbauer, Ryan D Morin, Bob Argiropoulos, et al.
Nature Methods|February 1, 2008
ALEXA: a microarray design platform for alternative expression analysisMalachi Griffith, Michelle J Tang, Obi L Griffith, et al.
Plos Computational Biology|June 1, 2011
deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq dataAndrew McPherson, Fereydoun Hormozdiari, Abdalnasser Zayed, et al.
Genome Medicine|November 14, 2024
pVACview: an interactive visualization tool for efficient neoantigen prioritization and selectionHuiming Xia, My H Hoang, Evelyn Schmidt, et al.
Nucleic Acids Research|November 5, 2015
DGIdb 2.0: mining clinically relevant drug-gene interactionsAlex H Wagner, Adam C Coffman, Benjamin J Ainscough, et al.
Blood|October 28, 2017
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trialNancy L Bartlett, Brian A Costello, Betsy R LaPlant, et al.
Pageof 17

Showing results (61-70 of 164) with videos related to

Sort By:
Pageof 17
Nature Genetics|November 7, 2018
A deep learning approach to automate refinement of somatic variant calling from cancer sequencing dataBenjamin J Ainscough, Erica K Barnell, Peter Ronning, et al.
Cell Reports|August 23, 2018
Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular HeterogeneityKatie M Campbell, Tianxiang Lin, Paul Zolkind, et al.
BMC Genomics|October 3, 2006
Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approachMatthew N Bainbridge, René L Warren, Martin Hirst, et al.
Arxiv|July 1, 2024
pVACview: an interactive visualization tool for efficient neoantigen prioritization and selectionHuiming Xia, My Hoang, Evelyn Schmidt, et al.
Genome Research|October 14, 2008
In-depth characterization of the microRNA transcriptome in a leukemia progression modelFlorian Kuchenbauer, Ryan D Morin, Bob Argiropoulos, et al.
Nature Methods|February 1, 2008
ALEXA: a microarray design platform for alternative expression analysisMalachi Griffith, Michelle J Tang, Obi L Griffith, et al.
Plos Computational Biology|June 1, 2011
deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq dataAndrew McPherson, Fereydoun Hormozdiari, Abdalnasser Zayed, et al.
Genome Medicine|November 14, 2024
pVACview: an interactive visualization tool for efficient neoantigen prioritization and selectionHuiming Xia, My H Hoang, Evelyn Schmidt, et al.
Nucleic Acids Research|November 5, 2015
DGIdb 2.0: mining clinically relevant drug-gene interactionsAlex H Wagner, Adam C Coffman, Benjamin J Ainscough, et al.
Blood|October 28, 2017
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trialNancy L Bartlett, Brian A Costello, Betsy R LaPlant, et al.
Pageof 17